Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Keratosis, Actinic 29Uterine Cervical Dysplasia 14Carcinoma, Basal Cell 12Melanoma 10Glioma 6Glioblastoma 6Breast Neoplasms 5Uterine Cervical Neoplasms 4Neoplasm Metastasis 4Keratosis 4Condylomata Acuminata 4Precancerous Conditions 3Papillomavirus Infections 3Hutchinson's Melanotic Freckle 3Vulvar Neoplasms 2Urinary Bladder Neoplasms 2Squamous Intraepithelial Lesions 2Non-Muscle Invasive Bladder Neoplasms 2Neoplasms 2Hemangioma, Capillary 2HIV Infections 2Ependymoma 2Colorectal Neoplasms 2Brain Neoplasms 2Astrocytoma 2Warts 1Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1Virus Diseases 1Vaginal Neoplasms 1Stomach Neoplasms 1

Interventions

Carboplatin 786Pemetrexed 609Cisplatin 547Paclitaxel 491pembrolizumab 465Docetaxel 440Gemcitabine 328Erlotinib Hydrochloride 307Radiotherapy 258Nivolumab 244Bevacizumab 233osimertinib 178Drug Therapy 164durvalumab 157atezolizumab 135Gefitinib 134Radiosurgery 133Vinorelbine 111Cetuximab 97130-nm albumin-bound paclitaxel 94Ipilimumab 86Magnetic Resonance Spectroscopy 84Taxes 79Surgical Procedures, Operative 74Afatinib 68Albumin-Bound Paclitaxel 66Specimen Handling 61Etoposide 61tislelizumab 60Cyclophosphamide 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Imiquimod × Clear all
NCT01909752 2017-07-06

Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer

UbiVac

Phase 2 Completed
12 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡